Cancer detection by serum analysis of glycolipids

Details Cancer detection by serum analysis of glycolipids Cancer detection by serum analysis of glycolipids

1977-06-13

1978-09-19

Reese, Robert M.

Chemistry: physical processes

Physical processes

Crystallization

424 12, G01N 3316

Patent

active

041150627

ABSTRACT:
In humans and experimental animals, serum levels of sialic acid-containing glycolipids are elevated 1.5 to 3 fold. A method is described whereby the ganglioside content is estimated on as little as 0.5 ml of serum or plasma. The procedure permits, based on the analysis of a single biochemical parameter, cancer detection applicable to a wide range of human and animal tumor types.

REFERENCES:
patent: B554039 (1976-02-01), Grosser et al.
patent: 3087862 (1963-04-01), Penn
patent: 4043757 (1977-08-01), Wagstaff

Affiliated with

Also associated with

Rating

Cancer detection by serum analysis of glycolipids does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cancer detection by serum analysis of glycolipids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cancer detection by serum analysis of glycolipids will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2116551